Clinical trial
Incremental Value of a Traditional Chinese Medicine-Integrated Versus Western-Only Strategy for Two-Stage Pre-Endoscopic Prediction of Colorectal Inflammatory Conditions: A Multicenter Diagnostic Model Development and External Validation Study
NCT07784114 is registered in ClinicalTrials.gov with Beijing University of Chinese Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Incremental Value of a Traditional Chinese Medicine-Integrated Versus Western-Only Strategy for Two-Stage Pre-Endoscopic Prediction of Colorectal Inflammatory Conditions: A Multicenter Diagnostic Model Development and External Validation Study
- Lead sponsor
- Beijing University of Chinese Medicine
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2015
- Completion date
- June 1, 2025
- Enrollment
- 1,500 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal neoplasms, crohn disease (cd), inflammatory bowel diseases, ulcerative colitis (disorder)